Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke
The capabilities of antithrombotic therapy to prevent thromboembolic events in nonvalvular atrial fibrillation (AF) are substantially extended after designing and clinically introducing new oral anticoagulants, one of which is dabigatran. A wealth of world clinical experience with dabigatran has con...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
IMA-PRESS LLC
2014-06-01
|
| Edice: | Неврология, нейропсихиатрия, психосоматика |
| Témata: | |
| On-line přístup: | https://nnp.ima-press.net/nnp/article/view/394 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|